Buy Acb Stock -

Professional outlooks on ACB are mixed, balancing its medical leadership against broader sector risks.

: While adjusted EBITDA reached $18.5 million , Aurora still reported a net loss of $51.6 million in Q3 2026, driven by costs rather than top-line movement alone. buy acb stock

: Reported $15.5 million in free cash flow for Q3 fiscal 2026, a critical milestone for long-term sustainability. Professional outlooks on ACB are mixed, balancing its

: Global medical cannabis now accounts for 81% of total revenue and 95% of adjusted gross profit , with medical margins holding steady at 69% . Market Sentiment & Ratings Professional outlooks on ACB are mixed